EC Number   |
Title |
Organism |
|---|
   2.4.2.12 | Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors |
Homo sapiens |
| 2.4.2.12 | Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer |
Homo sapiens |
| 2.4.2.12 | Identification of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors endowed with antiproliferative and antiinflammatory activity |
Mus musculus |
| 2.4.2.12 | Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group |
Homo sapiens |
| 2.4.2.12 | Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase |
Mus musculus |
| 2.4.2.12 | MicroRNA410 inhibits pulmonary vascular remodeling via regulation of nicotinamide phosphoribosyltransferase |
Homo sapiens |
| 2.4.2.12 | Nicotinamide phosphoribosyltransferase (Nampt)/nicotinamide adenine dinucleotide (NAD) axis suppresses atrial fibrillation by modulating the calcium handling pathway |
Mus musculus |
| 2.4.2.12 | Nicotinamide phosphoribosyltransferase purification using SUMO expression system |
Mus musculus |
| 2.4.2.12 | Nicotinamide phosphoribosyltransferase regulates cocaine reward through sirtuin 1 |
Mus musculus |
| 2.4.2.12 | Novel mechanism for nicotinamide phosphoribosyltransferase inhibition of TNF-alpha-mediated apoptosis in human lung endothelial cells |
Homo sapiens |
